Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Strategies in Biomarker Research
-
55 min
1. The proteomic revolution- Dr. Larry Gold
-
39 min
2. Lipid biomarkers: lipidomics of the macrophage and plasma lipidomes- Prof. Edward A. Dennis
- New Tools for Biomarker Research
-
38 min
-
31 min
-
59 min
5. Development of glyco-biomarkers using glycoproteomics technologies- Dr. Hisashi Narimatsu
-
32 min
6. Circulating nucleic acids as biomarkers in cancer patients- Prof. Klaus Pantel
- Specific Disease Applications
-
28 min
7. Biomarkers in breast cancer- Prof. Joe Duffy
-
71 min
8. Bacterial biomarkers- Dr. Christiane Honisch
-
32 min
9. Diabetes biomarkers- Prof. Naveed Sattar
-
60 min
10. Gene networks, brain networks: understanding schizophrenia- Dr. Daniel Weinberger
-
29 min
11. Biomarkers for Huntington's disease - promises and challenges- Prof. Sarah Tabrizi
-
31 min
12. Update on fluid biomarkers for neurodegenerative diseases- Prof. Henrik Zetterberg
-
31 min
13. Biomarkers in osteoarthritis- Dr. Ali Mobasheri
- Biomarkers in Drug Discovery and Delivery
-
31 min
14. Pharmacogenomics: emphasis on clinical drug development- Dr. Amelia Warner
-
25 min
15. Biomarkers in drug development: potential use and challenges- Dr. Abdel-Bassett Halim
-
41 min
- Biomarkers in development, nutrition, and health
-
50 min
-
29 min
18. Ethnic differences in nutrition- Prof. Jose Ordovas
-
55 min
19. Non-invasive prenatal diagnostics- Prof. Y. M. Dennis Lo
-
44 min
20. Epigenetic biomarkers in cancer- Prof. Bob Brown
- Archived Lectures *These may not cover the latest advances in the field
-
23 min
21. Biomarkers for Alzheimer's disease- Prof. Henrik Zetterberg
Printable Handouts
Navigable Slide Index
- Introduction
- Cell-free nucleic acids in cancer patients' blood
- Serum/plasma DNA vs. tumor tissue DNA
- Circulating DNA & nucleosides in breast tumors
- LOCH frequency on cell-free DNA in the serum
- Monitoring of the efficacy of systemic therapies
- Circulating DNA in ovarian cancer patients
- Circulating microns (mires) as biomarkers
- Circulating mires in breast cancer
- Circulating mires in ovarian cancer
- Circulating mires in lung cancer (NASAL)
- Cell-free DNA as an indicator of disease
- Tumor cell circulation and cancer dormancy
- CATCH & the microenvironment of metastasis sites
- CATCH enrichment methods
- CTC/DTC identification methods
- Detection of circulating tumor cells by EPISPOT
- Circulating free DNA & CATCH in prostate cancer (1)
- Circulating free DNA & CATCH in prostate cancer (2)
- Detection of DTC in bone marrow
- Circulating free DNA as potential DTC biomarker
- Molecular characterization of single CATCH
- Genetic analysis of single CATCH in CRC patients
- KRAS mutation analysis on plasma DNA
- Genomic profiling of a single CATCH by CGH
- Conclusions
- Circulating nucleic acids in cancer patients
- Cell-free DNA induces oncogenic transformation
- Cell-free DNA as bio-markers - review
Topics Covered
- Circulating Nucleic Acids
- Advantages of Serum/Plasma DNA vs. Tumor Tissue DNA
- Circulating DNA in patients with benign disease and malignant tumors
- Circulating microRNAs in cancer patients
- Associations between Circulating Tumor Cells and cell-free tumor DNA in cancer patients
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pantel, K. (2012, September 27). Circulating nucleic acids as biomarkers in cancer patients [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/CPUY7210.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Klaus Pantel has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Circulating nucleic acids as biomarkers in cancer patients
Published on September 27, 2012
32 min
